Thymidylate synthase activity, folates, and glutathione system in head and neck carcinoma and adjacent tissues

Head & Neck

Volumn 16, Issue 2, 1994, Pages 158-164

  Parise, Orlando ^a   Janot, François ^a   Luboinski, Bernard ^a   Massaad, Liliane ^a   Albin, Nicolas ^a   Toussaint, Caroline ^a   Verjus, Marie‐Ange ^a   Bonnay, Marc ^a   Gouyette, Alain ^a   Chabot, Guy G ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLIC ACID; GLUTATHIONE TRANSFERASE; THYMIDYLATE SYNTHASE;

ARTICLE; CANCER CHEMOTHERAPY; DRUG RESISTANCE; DRUG SENSITIVITY; ENZYME ACTIVITY; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SPECTROPHOTOMETRY; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DRUG RESISTANCE; FEMALE; FLUOROURACIL; FOLIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE TRANSFERASE; HEAD AND NECK NEOPLASMS; HUMAN; LARYNGEAL MUCOSA; MALE; MIDDLE AGE; MOUTH MUCOSA; NEOPLASM STAGING; PROTEINS; SUPPORT, NON-U.S. GOV'T; THYMIDYLATE SYNTHASE;

EID: 0028263050     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.2880160210     Document Type: Article

References (37)

1. Head and neck cancer
2. Head and neck cancer: chemotherapy concepts
3. Adjuvant chemotherapy for head and neck cancer [Editorial]
4. Glutathione S‐transferases: role in alkylating agent resistance and possible target for modulation chemotherapy—a review
5. Molecular basis of cisplatin resistance in carcinomas: model systems and patients
6. Glutathione S‐transferases and drug resistance
7. Fluorinated pyrimidines
8. Mechanism of innate resistance to thymidylate synthase inhibition after 5‐fluorouracil
9. Prospective randomized comparison of fluorouracil versus fluorouracil and high‐dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy
10. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma
11. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma
12. New vistas for leucovorin in cancer chemotherapy
13. Assay of glutathione, glutathione dissulfide, and glutathione mixed disulfides in biological samples
14. Glutathione S‐transferases. The first enzymatic step in mercapturic acid formation
15. Assays for differentiation of glutathione S‐transferases
16. Determination of thymidylate synthase activity in colon tumor tissues after treatment with 5‐fluorouracil
17. Measurement of protein using bicinchoninic acid
18. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein‐dye binding
19. Glutathione metabolism as a determinant of therapeutic efficacy: a review
20. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line
21. Rapid emergence of acquired cisdiamminedichloroplatinun (II) resistance in an in vivo model of human ovarian carcinoma
22. Reduced levels of drug‐induced DNA cross‐linking in nitrogen mustard‐resistant Chinese hamster ovary cells expressing elevated glutathione S‐transferase activity
23. Differences among human tumor cell lines in the expression of glutathione transferases and other glutathione‐linked enzymes
24. Glutathione depletion in tissues after administration of buthionine sulphoximine
25. No role for glutathione S‐transferases (GST) in vivo drug resistance to cis‐platinun/cyclophosphamide in ovarian cancer [Abstract]
26. Expression of anionic glutathione S‐transferase and P‐glycoprotein genes in human tissues and tumors
27. Cellular glutathione and thiol measurements from surgically resected human lung tumor and normal lung tissue
28. Pyrimidine antagonists
29. Salvage therapy of breast cancer with fluorouracil and high‐dose leucovorin: response correlations with tumor pharmacodynamics [Abstract]
30. Clinical relevance of biochemical modulation of 5‐fluorouracil
31. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT‐diaphorase gene expression in human tumors using the polymerase chain reaction
32. Folic acid metabolism and its disruption by pharmacologic agents
33. 10‐propargyl‐5,8‐dideazafolic acid (CB 3717)
34. Activity of thymidylate synthase, thymidylate kinase and galactokinase in primary and xenografted human colorectal cancer in relation to their chromosomal patterns
35. 5‐Fluorouracil and UFT‐sensitive gastric carcinoma has a high level of thymidylate synthase
36. Comparison of pyrimidine nucleotide synthetic enzymes involved in 5‐fluorouracil metabolism between human adenocarcinomas and squamous cell carcinomas